4 reports of this reaction
2.1% of all DIPHENHYDRAMINE CITRATE, IBUPROFEN reports
#6 most reported adverse reaction
INSOMNIA is the #6 most commonly reported adverse reaction for DIPHENHYDRAMINE CITRATE, IBUPROFEN, manufactured by Family Dollar (FAMILY WELLNESS). There are 4 FDA adverse event reports linking DIPHENHYDRAMINE CITRATE, IBUPROFEN to INSOMNIA. This represents approximately 2.1% of all 188 adverse event reports for this drug.
Patients taking DIPHENHYDRAMINE CITRATE, IBUPROFEN who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INSOMNIA is a less commonly reported adverse event for DIPHENHYDRAMINE CITRATE, IBUPROFEN, but still significant enough to appear in the safety profile.
In addition to insomnia, the following adverse reactions have been reported for DIPHENHYDRAMINE CITRATE, IBUPROFEN:
The following drugs have also been linked to insomnia in FDA adverse event reports:
INSOMNIA has been reported as an adverse event in 4 FDA reports for DIPHENHYDRAMINE CITRATE, IBUPROFEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
INSOMNIA accounts for approximately 2.1% of all adverse event reports for DIPHENHYDRAMINE CITRATE, IBUPROFEN, making it a notable side effect.
If you experience insomnia while taking DIPHENHYDRAMINE CITRATE, IBUPROFEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.